Pfizer CEO Bourla: Omicron-specific Covid vaccine will be ready by March

Share

Pfizer CEO Albert Bourla sits down with CNBC’s Meg Tirrell and the ‘Squawk Box’ team to discuss the company’s Covid-19 vaccine booster strategy, including a potential shot targeting the omicron variant.